Robert C. Griggs

What is he best known for?

The fields of study he is best known for:

• Internal medicine
• Disease
• Surgery

Robert C. Griggs mostly deals with Internal medicine, Surgery, Endocrinology, Muscular dystrophy and Pathology. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Periodic paralysis. The Surgery study combines topics in areas such as Placebo, Anesthesia and Duchenne muscular dystrophy.

As a part of the same scientific family, Robert C. Griggs mostly works in the field of Placebo, focusing on Clinical trial and, on occasion, Natural history and Disease. Robert C. Griggs works mostly in the field of Endocrinology, limiting it down to concerns involving Myotonia and, occasionally, Muscle disorder. His biological study spans a wide range of topics, including Deflazacort, Physical therapy and Muscle biopsy.

His most cited work include:

• Inclusion body myositis and myopathies. (646 citations)
• Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy (423 citations)
• Clinical trial in duchenne dystrophy. I. The design of the protocol (405 citations)

What are the main themes of his work throughout his whole career to date?

Robert C. Griggs focuses on Internal medicine, Endocrinology, Duchenne muscular dystrophy, Myotonia and Clinical trial. His Internal medicine study combines topics from a wide range of disciplines, such as Placebo, Weakness and Cardiology. His research integrates issues of Anesthesia and Adverse effect in his study of Placebo.

His work carried out in the field of Duchenne muscular dystrophy brings together such families of science as Randomized controlled trial, Muscular dystrophy, Prednisone, Physical therapy and Pediatrics. His Muscular dystrophy research is included under the broader classification of Genetics. His research in Myotonia focuses on subjects like Periodic paralysis, which are connected to Hypokalemic periodic paralysis.

He most often published in these fields:

• Internal medicine (25.23%)
• Endocrinology (14.35%)
• Duchenne muscular dystrophy (11.57%)

What were the highlights of his more recent work (between 2008-2021)?

• Internal medicine (25.23%)
• Duchenne muscular dystrophy (11.57%)
• Physical therapy (8.56%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Duchenne muscular dystrophy, Physical therapy, Pediatrics and Clinical trial. His Internal medicine research is multidisciplinary, incorporating elements of Placebo, Periodic paralysis, Endocrinology and Cardiology. He interconnects Muscular dystrophy, Newborn screening, Bioinformatics and Spinal muscular atrophy in the investigation of issues within Duchenne muscular dystrophy.

His Pediatrics study integrates concerns from other disciplines, such as Neurology and Genetic testing. In his research, Orphan drug is intimately related to Intensive care medicine, which falls under the overarching field of Clinical trial. Robert C. Griggs has researched Myotonia in several fields, including Weakness and Pathology.

Between 2008 and 2021, his most popular works were:

• Clinical research for rare disease: opportunities, challenges, and solutions. (234 citations)
• The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment (137 citations)
• Evidence-based guideline summary: Diagnosis and treatment of limb-girdle and distal dystrophies Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine (115 citations)

In his most recent research, the most cited papers focused on:

• Internal medicine
• Disease
• Gene

Physical therapy, Internal medicine, Myotonia, Duchenne muscular dystrophy and Pediatrics are his primary areas of study. He combines subjects such as Neurology, Clinical trial and Evidence-based medicine, MEDLINE with his study of Physical therapy. His research links Endocrinology with Internal medicine.

His Myotonia research is multidisciplinary, incorporating perspectives in Periodic paralysis, Mexiletine and Pathology. Robert C. Griggs has included themes like Muscular dystrophy, Newborn screening and Myostatin in his Duchenne muscular dystrophy study. His Pediatrics research includes themes of Muscle biopsy, Status epilepticus, Genetic testing and Subarachnoid hemorrhage.